{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:28:37Z","timestamp":1793766517768,"version":"4.6.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1227\/neu.0b013e3182367272","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:06:28Z","timestamp":1317737188000},"page":"860-867","source":"Crossref","is-referenced-by-count":39,"title":["Performing a Cost Analysis in Spine Outcomes Research"],"prefix":"10.1227","volume":"70","author":[{"given":"Robert G.","family":"Whitmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Sanford","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherman C.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoher","family":"Ghogawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R1-19-20230417","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jama.299.6.656","article-title":". Expenditures and health status among adults with back and neck problems.","volume":"299","author":"Martin","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"R3-19-20230417","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1377\/hlthaff.2010.0623","article-title":"How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement.","volume":"29","author":"Pearson","year":"2010","journal-title":"Health Aff (Millwood)"},{"issue":"13","key":"R4-19-20230417","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMp0906490","article-title":"New, but not improved Incorporating comparative-effectiveness information into FDA labeling.","volume":"361","author":"Stafford","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"R5-19-20230417","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2009.1186","article-title":"Institute of Medicine outlines priorities for comparative effectiveness research.","volume":"302","author":"Kuehn","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"R6-19-20230417","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0266462309990225","article-title":"Comparative effectiveness research priorities: identifying critical gaps in evidence for clinical and health policy decision making.","volume":"25","author":"Chalkidou","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"R8-19-20230417","first-page":"199","article-title":"The EuroQol Group.","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"1","key":"R9-19-20230417","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11136-007-9292-3","article-title":". Health-related quality of life of day-case surgery patients: a preposttest survey using the EuroQoL-5D.","volume":"17","author":"Suhonen","year":"2008","journal-title":"Qual Life Res"},{"issue":"2","key":"R11-19-20230417","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00024720-200304000-00002","article-title":"Treatment of multilevel cervical spondylotic myeloradiculopathy with posterior decompression and fusion with lateral mass plate fixation and local bone graft.","volume":"16","author":"Huang","year":"2003","journal-title":"J Spinal Disord Tech"},{"issue":"3","key":"R14-19-20230417","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1227\/NEU.0b013e31820777cf","article-title":". Comparative effectiveness of ventral versus dorsal surgery for cervical spondylotic myelopathy.","volume":"68","author":"Ghogawala","year":"2011","journal-title":"Neurosurgery"},{"issue":"4","key":"R15-19-20230417","first-page":"349","article-title":"What does the value of modern medicine say about the 50,000 per quality-adjusted life-year decision rule Med Care.","volume":"46","author":"Braithwaite","year":"2008","journal-title":""},{"issue":"5","key":"R16-19-20230417","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group.","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"11","key":"R17-19-20230417","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","article-title":"Deriving a preference-based single index from the UK SF-36 Health Survey.","volume":"51","author":"Brazier","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"R18-19-20230417","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality-of-life outcomes.","volume":"334","author":"Testa","year":"1996","journal-title":"N Engl J Med"},{"issue":"14","key":"R19-19-20230417","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine: Panel on Cost-Effectiveness Health Medicine.","volume":"276","author":"Russell","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"R20-19-20230417","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values.","volume":"36","author":"Gold","year":"1998","journal-title":"Med Care"},{"issue":"2","key":"R21-19-20230417","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36.","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"issue":"suppl 1","key":"R23-19-20230417","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics.","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"issue":"5","key":"R24-19-20230417","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11136-004-5743-2","article-title":"Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants.","volume":"14","author":"McDonough","year":"2005","journal-title":"Qual Life Res"},{"issue":"suppl 3","key":"R25-19-20230417","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00586-009-0939-3","article-title":"The impact of economic evaluation on quality management in spine surgery.","volume":"18","author":"Boos","year":"2009","journal-title":"Eur Spine J"},{"issue":"18","key":"R26-19-20230417","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2165\/00019053-200422180-00005","article-title":"The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios.","volume":"22","author":"Chumney","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"suppl 1","key":"R27-19-20230417","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1007\/s00586-005-1052-x","article-title":"Economic evaluations: a new avenue of outcome assessment in spinal disorders.","volume":"15","author":"van der Roer","year":"2006","journal-title":"Eur Spine J"},{"issue":"4","key":"R28-19-20230417","first-page":"442","article-title":"Economic evaluations and randomized trials in spinal disorders: principles and methods. Spine (Phila Pa 1976).","volume":"29","author":"Korthals-de Bos","year":"2004","journal-title":""},{"issue":"2","key":"R30-19-20230417","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/002570879104800203","article-title":"Assessing Medicares prospective payment system for hospitals.","volume":"48","author":"Chulis","year":"1991","journal-title":"Med Care Rev"},{"issue":"1","key":"R31-19-20230417","first-page":"1","article-title":"Practical options for estimating cost of hospital inpatient stays.","volume":"29","author":"Friedman","year":"2002","journal-title":"J Health Care Finance"},{"issue":"2","key":"R33-19-20230417","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737167.5.2.153","article-title":"Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis.","volume":"5","author":"Tumeh","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"R34-19-20230417","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00019053-200927030-00001","article-title":"Costing and cost analysis in randomized controlled trials: caveat emptor.","volume":"27","author":"Polsky","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"R35-19-20230417","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1524-4733.2005.00045.x","article-title":". Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.","volume":"8","author":"Ramsey","year":"2005","journal-title":"Value Health"},{"issue":"5","key":"R36-19-20230417","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2165\/00019053-199610050-00003","article-title":"A practical guide for calculating indirect costs of disease.","volume":"10","author":"Koopmanschap","year":"1996","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"R37-19-20230417","first-page":"135","article-title":"Measuring indirect costs: is there a problem Appl Health Econ Health Policy.","volume":"2","author":"Sach","year":"2003","journal-title":""},{"issue":"9","key":"R38-19-20230417","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means.","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"R39-19-20230417","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3171\/2010.3.SPINE09552","article-title":"Cost-effectiveness of current treatment strategies for lumbar spinal stenosis: nonsurgical care, laminectomy, and X-STOP.","volume":"13","author":"Burnett","year":"2010","journal-title":"J Neurosurg Spine"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/70\/4\/860\/32586371\/00006123-201204000-00019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201204000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:53:31Z","timestamp":1786121611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201204000-00019"}},"subtitle":["Comparing Ventral and Dorsal Approaches for Cervical Spondylotic Myelopathy"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1227\/neu.0b013e3182367272","relation":{},"ISSN":["0148-396X"],"issn-type":[{"value":"0148-396X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}